1. Home
  2. UBXG vs NSRX Comparison

UBXG vs NSRX Comparison

Compare UBXG & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U-BX Technology Ltd. Ordinary Shares

UBXG

U-BX Technology Ltd. Ordinary Shares

HOLD

Current Price

$7.32

Market Cap

34.8M

Sector

N/A

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.07

Market Cap

36.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBXG
NSRX
Founded
2018
2019
Country
China
Israel
Employees
N/A
7
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.8M
36.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
UBXG
NSRX
Price
$7.32
$3.07
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
2.0M
41.8K
Earning Date
06-18-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$1.98
52 Week High
$12.88
$9.99

Technical Indicators

Market Signals
Indicator
UBXG
NSRX
Relative Strength Index (RSI) 68.71 50.63
Support Level $1.32 $2.78
Resistance Level N/A $3.58
Average True Range (ATR) 1.53 0.27
MACD 0.47 -0.00
Stochastic Oscillator 44.45 32.17

Price Performance

Historical Comparison
UBXG
NSRX

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry, including insurance carriers and brokers. Its main offerings include three services/products: digital promotion services, risk assessment services, and value-added bundled benefits. The PRC operating entities help their institutional clients gain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or clients' promotion time on these channels. U-BX Beijing developed a unique algorithm named the Magic Mirror. The majority of revenue comes from digital promotion services. Geographically, all of the company's revenue is derived from Mainland China.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: